As of 2026-08-24, Penumbra, Inc. (PEN) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 0.7%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
PEN is held by 41 ETFs as of May 2026. Top owner: VHT at 0.19% weight, $36M notional. Top 3 carry $96M.
Held by 121 ETFs · $2.5B across latest filings · largest weight 12.36% (RSBA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.19% | $36M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.23% | $34M | −0.04 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.04% | $27M | — |
| QGRO | 0.94% | $21M | +0.56 pp |
| IVOO | 0.36% | $20M |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.03 pp |
| VONGVanguard Russell 1000 Growth ETF | 0.04% | $20M | — |
| CGMM | 0.50% | $14M | new |
| SCHXSchwab U.S. Large-Cap ETF | 0.02% | $13M | — |
| IVOG | 0.68% | $13M | −0.07 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.02% | $7M | — |
Showing 10 of 41 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PEN Jan avg: 10.11% median: 12.49% win: 100% σ: 6.69% n: 4 2022-04-12 → 2026-07-31 | PEN Feb avg: 0.01% median: -0.01% win: 50% σ: 6.43% n: 4 2022-04-12 → 2026-07-31 | PEN Mar avg: -2.19% median: -4.83% win: 25% σ: 6.30% n: 4 2022-04-12 → 2026-07-31 | PEN Apr avg: -3.00% median: -0.58% win: 40% σ: 9.82% n: 5 2022-04-12 → 2026-07-31 | PEN May avg: -4.32% median: -3.56% win: 20% σ: 8.54% n: 5 2022-04-12 → 2026-07-31 | PEN Jun avg: -2.60% median: -3.87% win: 20% σ: 9.78% n: 5 2022-04-12 → 2026-07-31 | PEN Jul avg: -1.41% median: -1.70% win: 40% σ: 9.08% n: 5 2022-04-12 → 2026-07-31 | PEN Aug avg: 8.53% median: 12.93% win: 75% σ: 15.26% n: 4 2022-04-12 → 2026-07-31 (current) | PEN Sep avg: -1.02% median: -5.52% win: 25% σ: 11.17% n: 4 2022-04-12 → 2026-07-31 | PEN Oct avg: -5.75% median: -9.90% win: 25% σ: 16.54% n: 4 2022-04-12 → 2026-07-31 | PEN Nov avg: 18.49% median: 19.18% win: 100% σ: 9.45% n: 4 2022-04-12 → 2026-07-31 | PEN Dec avg: 5.69% median: 6.12% win: 75% σ: 6.54% n: 4 2022-04-12 → 2026-07-31 |